Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Jan 02, 2020 7:21am

121 Views

Post# 30510202

RE:RE:RE:RE:RE:RE:Proof Is In The Pudding

winr88 wrote

Hi investclub

It seems that a few posters such as bigkagan think there is nothing happening. Starting as early as tomorrow, announcements of new trial patients and trial locations could be announced.

Hi winr88 Yes maybe he just thinks what most posters are saying about the company releasing batch NR's are wrong or he just hasn't read those posts ... That is fact this company will now release two or more updates in one release. I have posted as have others we are under the impression news will start coming out in January ... I personally have said for awhile January 6th is the earliest

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments